Back to ACAD
BAKER BROS. ADVISORS LP → ACAD
BAKER BROS. ADVISORS LP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
4
Latest value
$864.7M
Q3 2026
Peak value
$1.1B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.1B |
| Q1 2026 | $954.9M |
| Q2 2026 | $1.1B |
| Q3 2026 | $864.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $864.7M | 42.91M | — | — |
| Q2 2026 | $1.1B | 42.91M | — | — |
| Q1 2026 | $954.9M | 42.90M | — | — |
| Q4 2025 | $1.1B | 42.90M | — | — |
Other funds holding ACAD
$386.3M
$383.2M
$377M
$323.1M
$322.9M
$310.4M
$302.7M